Outsourced Drug Discovery Market Scope
The pharmaceutical companies are progressively outsourcing research activities to private and academic contract research organizations (CROs) as a method to stay competitive and flexible in exponentially growing knowledge, gradually refined technologies and an uneven economic environment. It is getting more expensive to develop new drugs, competition from generics is increasing, investors expect double-digit growth, complaints from consumers and payers about excessive drug prices are more strident, and the number of new drugs reaching the market each year is below expectations.
The market study is being classified, by Application (Oncology, Ophthalmology, Hematology, Immunomodulation, Anti-Infective Drugs, Dermatology, Neurology, Cardiology and Others) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Outsourced Drug Discovery market throughout the predicted period.
Charles River (United States), EVOTEC (Germany), Laboratory Corporation of America Holdings (United States), GenScript, Merck & Co., Inc. (United States), Thermo Fisher Scientific, Inc. (United States), Oncodesign (France), Albany Molecular Research, Inc. (United States), Dalton Pharma Services (Canada), Pharmaceutical Product Development, LLC (United States), DiscoverX Corporation (United States), Bioduro LLC (United States) and Syngene International Ltd. (India) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Sundia Meditech Co. Ltd. (China) and WuXi AppTec (China).
AdvanceMarketAnalytics has segmented the market of Global Outsourced Drug Discovery market by Type, Application and Region.
On the basis of geography, the market of Outsourced Drug Discovery has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
- Increasing Trend of Outsourcing Manufacturing and R&D Activities to Countries such as China and India
- Rapidly Adoption of the Artificial Intelligence and Deep Learning Technology
- Growing Number of CRO, CMOs, and CDMOs in Emerging Countries
- Rising Demand for the Biological Drugs
- Rising Demand of Small Molecule Drugs for Treating Chronic Diseases
- Increasing Healthcare Expenditure in the Developing Economies
- High Capital Investment for the Drug Discovery Settings
- Unknown Regulation Complications and Duplication Problems
Key Target AudienceDrug Discovery Outsourced Providers, Pharmaceutical Industry, Biotechnological Companies, Governmental Bodies, Downstream Vendors and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase